申请人:Fondazione Istituto Insubrico di Ricerca per la Vita
公开号:US20190002942A1
公开(公告)日:2019-01-03
An antibiotic FIIRV 104/18 complex comprising factors F793, F795, F797, F813 and F683, of formula (I), wherein R represents a glycosidic radical as defined in the specification, the isolated individual factors, a method for their production by cultivation of
Dactylosporangium
FIIRV sp. 104/18 DSM 32068 under aerobic conditions, and pharmaceutical formulations containing them as active ingredient and their use in the treatment of bacterial infections, caused by bacteria of at least one of the genera
Enterococci, Streptococci, Staphylococci
and
Moraxella
, including bacteria of multi resistant strains, in particular
Staphylococcus
spp.,
Streptococcus
spp, and
Enterococcus
spp. resistant to methicillin and/or vancomycin.